官方服务：
资源简介：
tumor immune signatures and neoantigen discovery in patients of Lynch syndrome
应用场景：
创建时间：
2020-10-26
相关数据集
Targeting the tumor mutanome for personalized vaccination in lung cancer. Targeting the tumor mutanome for personalized vaccination in lung cancer
Cancer is characterized by an accumulation of somatic mutations, of which a significant subset can generate cancer-specific neoepitopes that are recognized by autologous T cells. Neoepitopes are emerg
NIAID Data Ecosystem70
Additional file 3 of Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
Additional file 3: This file includes the information about all epitopes identified from fusion proteins for each patient.
Figshare2024-08-20 更新50
Whole Exome Sequening of B16F10 melanoma mouse model for ATLAS identification.
The ATLAS bioassay was developed to empirically identify neoantigens by expressing each unique patient-specific tumor mutation individually in E. coli, pulsing autologous dendritic cells in an ordered
NIAID Data Ecosystem30
Supplementary Table 2 from Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity
Characterization of tier 1 mutations identified in WHIM30 through NSG.
Figshare2017-07-01 更新60
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Study EGAS00001003886EGA study EGAS00001003886
NIAID Data Ecosystem30
